Life sciences AI for every team that writes, reviews, and approves

One platform for every team

From nonclinical summaries and clinical study reports to safety reports, health authority responses, and manuscripts, see how Artos puts your team’s knowledge to work across critical workflows.

AI for clinical writing

Documents: Clinical study reports · Investigator’s brochures · Narratives · Plain-language summaries for trial disclosure

Write once, reuse across documents, and keep content aligned as source data changes, giving writers more time to focus on the science.

✓

Every document drafted in your team’s voice, from your own source data

✓

The same terms, values, and abbreviations across every document

AI for medical writing

Documents: Clinical study reports · Investigator’s brochures · Narratives · Plain-language summaries for trial disclosure

Write once, reuse across documents, and keep content aligned as source data changes, giving writers more time to focus on the science.

✓

Every document drafted in your team’s voice, from your own source data

✓

The same terms, values, and abbreviations across every document

AI for medical writing

Documents: Clinical study reports · Investigator’s brochures · Narratives · Plain-language summaries for trial disclosure

Write once, reuse across documents, and keep content aligned as source data changes, giving writers more time to focus on the science.

✓

Every document drafted in your team’s voice, from your own source data

✓

The same terms, values, and abbreviations across every document

AI for nonclinical writing

Documents: Nonclinical overviews and summaries (Module 2.4 and 2.6) · Toxicology and pharmacology reports

Turn study reports and tabulated data into nonclinical summaries that stay aligned with their sources, from toxicology and pharmacology findings to the IND.

✓

Nonclinical written and tabulated summaries drafted from your study reports

✓

Every value traced back to the study it came from

AI for CMC authoring

Documents: Module 3 quality sections · CMC content for INDs, NDAs, and BLAs

Keep Module 3 aligned with current specifications, methods, and batch data. See where changes have an impact and draft updates across affected sections and regions.

✓

3.2.S and 3.2.P sections drafted from your source data

✓

See every section and region a change affects before review

AI for safety reporting

Documents: DSURs · PSURs and PBRERs · Safety narratives

Draft aggregate safety reports from your latest data, with every number checked against its source and the same safety language from one reporting period to the next.

✓

DSURs, PSURs, and PBRERs drafted from your safety data

✓

Consistent safety messaging across reports and periods

AI for regulatory affairs

Documents: INDs, NDAs, BLAs, and CTD modules, with eCTD-ready output · Briefing books · Labeling

Trace claims back to their sources, respond to health authority questions, and see how changes in FDA, EMA, or ICH guidance affect your programs.

✓

Briefing books and health authority query responses drafted from the same data as the dossier

✓

Labeling kept consistent with your latest data and guidance

AI for medical communications

Documents: Manuscripts · Publications

Draft publications and manuscripts from the same approved data as your clinical documents, so results and claims match across what you submit and what you publish.

✓

Manuscripts drafted from your study data and approved content

✓

The same results and messaging across publications and regulatory documents

Artos’s approach doesn’t just consider what sponsors need. It considers what the whole ecosystem needs, regulators included.

Douglas Throckmorton, MD

Former Deputy Center Director for Regulatory Programs

FDA Center for Drug Evaluation and Research (CDER)

Artos’s approach doesn’t just consider what sponsors need. It considers what the whole ecosystem needs, regulators included.

Douglas Throckmorton, MD

Former Deputy Center Director for Regulatory Programs

FDA Center for Drug Evaluation and Research (CDER)

Artos’s approach doesn’t just consider what sponsors need. It considers what the whole ecosystem needs, regulators included.

Douglas Throckmorton, MD

Former Deputy Center Director for Regulatory Programs

FDA Center for Drug Evaluation and Research (CDER)

Artos’s approach doesn’t just consider what sponsors need. It considers what the whole ecosystem needs, regulators included.

Douglas Throckmorton, MD

Former Deputy Center Director for Regulatory Programs

FDA Center for Drug Evaluation and Research (CDER)

Pick a workflow, and we’ll walk your team through it.

Pick a workflow, and we’ll walk your team through it.

Pick a workflow, and we’ll walk your team through it.

By organization

How Artos fits your organization

Our team has done this work at Bristol Myers Squibb, Parexel, IQVIA, and Verily, so we know what each kind of organization is up against.

Biotech and mid-size pharma

Do more of the critical work with the team you have

As your portfolio grows, Artos helps your team take on more critical work by building on the knowledge, content, and decisions already in place.

Why teams choose Artos

•

No data team needed: templates, agents, and governance built in

•

Every new document starts from approved content

•

Less rework across files and versions

Biotech and mid-size pharma

Do more of the critical work with the team you have

As your portfolio grows, Artos helps your team take on more critical work by building on the knowledge, content, and decisions already in place.

Why teams choose Artos

•

No data team needed: templates, agents, and governance built in

•

Every new document starts from approved content

•

Less rework across files and versions

Enterprise

Build on what you’ve already built

Your systems, data, and AI investments are already part of how your organization works. Artos brings company knowledge and context into new workflows while fitting into the infrastructure you have in place.

Why teams choose Artos

•

Protects what you’ve invested in content, systems, and AI

•

Granular permissions, versioning, and approvals built in

•

Your agents and partner agents on one governed foundation

Enterprise

Build on what you’ve already built

Your systems, data, and AI investments are already part of how your organization works. Artos brings company knowledge and context into new workflows while fitting into the infrastructure you have in place.

Why teams choose Artos

•

Protects what you’ve invested in content, systems, and AI

•

Granular permissions, versioning, and approvals built in

•

Your agents and partner agents on one governed foundation

CRO/CDMO

Your expertise shouldn’t start over with every client

Work in each sponsor’s templates or your own, and keep every sponsor’s data separate. Your proven methods and agents carry from one engagement to the next, so your team delivers consistently as the business grows.

Why teams choose Artos

•

Sponsor templates or your own

•

Each sponsor’s data kept separate

•

Your methods and agents, reused on every engagement

CRO/CDMO

Your expertise shouldn’t start over with every client

Work in each sponsor’s templates or your own, and keep every sponsor’s data separate. Your proven methods and agents carry from one engagement to the next, so your team delivers consistently as the business grows.

Why teams choose Artos

•

Sponsor templates or your own

•

Each sponsor’s data kept separate

•

Your methods and agents, reused on every engagement

How customers use Artos

Reach
4
teams per organization, on average
Engagement
72%
teams active weekly
Beyond the draft
64%
of activity comes after the first draft

Common questions

Common questions

Which other teams use the platform?

Clinical, quality, and medical affairs teams use it too, along with the reviewers and leaders who sign off on the work.

Does Artos work with large pharma, biotech, and CROs?

Yes. Large pharma teams get enterprise governance, permissions, and integrations. Biotechs take on more critical work with the team they have. CROs and CDMOs work in each sponsor’s templates and keep each sponsor’s data separate, while reusing their own methods and agents.

Can different teams in the same organization use the platform differently?

Yes. Medical writing, nonclinical, CMC, safety, regulatory, and medical communications teams each get document types and workflows suited to their work, all built on the same source data. When one team updates a value, agents draft the change in every document that uses it, across teams.

Do our writers need technical or AI skills?

No. People keep working in the systems they already use, and inside the platform they work in familiar views: a document, a review pane, or a chat box. There’s no prompt engineering to learn and no data team needed.

How do reviewers and QA teams use the platform?

Reviewers can trace every sentence to its source and see the agent’s reasoning. QA teams use the Checklist agent to check documents against SOPs and quality requirements, while the QC agent verifies data points against their sources.

Can our data team use the structured data directly?

Yes. The schema is open and documented, so teams can build their own pipelines to move data into and out of the Artos platform for big data projects, analytics dashboards, customizations, and more.

Documents get filed. Data builds.

Tell us about your team, and we’ll walk through drafting, review, verification, and updates on work like yours.

Documents get filed. Data builds.

Tell us about your team, and we’ll walk through drafting, review, verification, and updates on work like yours.